| Symbol | IMCC |
|---|---|
| Name | IM CANNABIS CORP. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medicinal Chemicals and Botanical Products |
| Address | CENTRAL DISTRICT, KIBBUTZ GLIL YAM, 4690500, Israel |
| Telephone | +972 544331111 |
| Fax | — |
| — | |
| Website | https://www.imcannabis.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001792030 |
| Description | IM Cannabis Corp is a Canada-based international medical cannabis company. It offers government-licensed cannabis products, from generic to GMP-certified and pharmaceutical-grade, for both wholesale and retail clients. The majority of its revenues are generated from sales of medical cannabis products to customers in Israel and recreational cannabis in Canada. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Additional info from NASDAQ: |
IM Cannabis Enters into Agreement to Sell IMC Holdings and European- Focused Assets
Read moreIM Cannabis Enters into Agreement to Sell IMC Holdings and European- Focused Assets
Read moreIM Cannabis Corp. Announces Second Quarter and First Half 2026 Financial Results
Read moreIM Cannabis Corp. Announces Second Quarter and First Half 2026 Financial Results
Read moreIM Cannabis Raises US$250,000 of Gross Proceeds in Convertible Note Financing
Read moreIM Cannabis Raises US$250,000 of Gross Proceeds in Convertible Note Financing
Read moreIM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing
Read moreIM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing
Read more